Adaptive Biotechnologies Corp (ADPT)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 35M 70M 105M Q3 '24: 46.4M Q4 '24: 47.5M Q1 '25: 52.4M Q2 '25: 58.9M Q3 '25: 94M Q4 '25: 71.7M Q1 '26: 70.9M Q2 '26: 71.6M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Gross Profit Quarterly

0 30M 60M 90M Q3 '24: 29.8M Q4 '24: 29.4M Q1 '25: 35.5M Q2 '25: 40.9M Q3 '25: 75.8M Q4 '25: 53.5M Q1 '26: 52.2M Q2 '26: 51.4M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Revenue minus cost of sales. This filer tags no gross profit of its own..

Operating Income Quarterly

-45M -30M -15M 0 15M 30M 45M Q3 '24: -32.6M Q4 '24: -33.8M Q1 '25: -29.6M Q2 '25: -25M Q3 '25: 10.3M Q4 '25: -12.8M Q1 '26: -19.2M Q2 '26: -15.8M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Net Income Quarterly

-45M -30M -15M 0 15M 30M 45M Q3 '24: -32.1M Q4 '24: -33.7M Q1 '25: -29.9M Q2 '25: -25.6M Q3 '25: 9.5M Q4 '25: -13.6M Q1 '26: -20M Q2 '26: -39.8M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Cost of Revenue Quarterly

0 7M 14M 21M Q3 '24: 16.7M Q4 '24: 18M Q1 '25: 17M Q2 '25: 18M Q3 '25: 18.2M Q4 '25: 18.2M Q1 '26: 18.7M Q2 '26: 20.2M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Operating Cash Flow Quarterly

-30M -20M -10M 0 10M 20M 30M Q3 '24: -27.1M Q4 '24: -12.5M Q1 '25: -28.5M Q2 '25: -12.4M Q3 '25: -7.1M Q4 '25: 2.1M Q1 '26: -9.5M Q2 '26: -6.4M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Free Cash Flow Quarterly

-30M -15M 0 15M 30M 45M Q3 '24: -27.4M Q4 '24: -12.6M Q1 '25: -29.7M Q2 '25: -13.1M Q3 '25: -7.5M Q4 '25: 1.4M Q1 '26: -10.3M Q2 '26: -7.6M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 60M 120M 180M Q1 '24: 145.8M Q2 '24: 147.4M Q3 '24: 147.5M Q1 '25: 149.2M Q2 '25: 152.1M Q3 '25: 163.2M Q1 '26: 155.5M Q2 '26: 159.9M Q1 '24 Q2 '24 Q3 '24 Q1 '25 Q2 '25 Q3 '25 Q1 '26 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-1.50 -1.00 -0.50 0.00 0.50 1.00 1.50 Q3 '24: -1.34 Q4 '24: -1.08 Q1 '25: -0.95 Q2 '25: -0.81 Q3 '25: -0.53 Q4 '25: -0.40 Q1 '26: -0.33 Q2 '26: -0.41 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.